Professor Arthur Bloom expressed concerns to Dr Holgate (DHSS). Firstly that material produced by a US company had been sold "through brokerage or other means" to Speywood where it had been relabelled as a product of their own. A second concern was that it had been reported Inter-Pharma intended to market cut price Factor 8 obtained from Cutter and from Hyland".